Design and Preclinical Evaluation of 68Ga-Labeled Covalently Modified Nectin-4 Targeting Peptide as a Potential Tumor Radiotracer
文献类型：期刊论文
| 作者 | Pei, Yang3; Zhou, Xu1; Sun, Mingyue1; Qiu, Shanshan1; Cheng, Zhen2; Hu, Ji1; Du, Jin3 |
| 刊名 | NUCLEAR MEDICINE AND BIOLOGY
 |
| 出版日期 | 2025-11-01 |
| 卷号 | 150页码:2 |
| ISSN号 | 0969-8051 |
| DOI | 10.1016/j.nucmedbio.2025.109324 |
| WOS研究方向 | Radiology, Nuclear Medicine & Medical Imaging |
| 语种 | 英语 |
| WOS记录号 | WOS:001632358100012 |
| 出版者 | ELSEVIER SCIENCE INC |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/322193]  |
| 专题 | 中国科学院上海药物研究所 |
| 作者单位 | 1.HTA Co Ltd, Beijing, Peoples R China 2.Shanghai Inst Mat Med, Shanghai, Peoples R China 3.China Isotope & Radiat Corp, Beijing, Peoples R China |
| 推荐引用方式 GB/T 7714 | Pei, Yang,Zhou, Xu,Sun, Mingyue,et al. Design and Preclinical Evaluation of 68Ga-Labeled Covalently Modified Nectin-4 Targeting Peptide as a Potential Tumor Radiotracer[J]. NUCLEAR MEDICINE AND BIOLOGY,2025,150:2. |
| APA | Pei, Yang.,Zhou, Xu.,Sun, Mingyue.,Qiu, Shanshan.,Cheng, Zhen.,...&Du, Jin.(2025).Design and Preclinical Evaluation of 68Ga-Labeled Covalently Modified Nectin-4 Targeting Peptide as a Potential Tumor Radiotracer.NUCLEAR MEDICINE AND BIOLOGY,150,2. |
| MLA | Pei, Yang,et al."Design and Preclinical Evaluation of 68Ga-Labeled Covalently Modified Nectin-4 Targeting Peptide as a Potential Tumor Radiotracer".NUCLEAR MEDICINE AND BIOLOGY 150(2025):2. |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。